The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula I are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula I and its therapeutic use.
Peptidomimetic macrocycles and use thereof in regulating HIF1alpha
申请人:AILERON THERAPEUTICS, INC.
公开号:US10246491B2
公开(公告)日:2019-04-02
The present invention provides peptidomimetic macrocycles capable of regulating HIF1α and methods of using such macrocycles for the treatment of diseases.
本发明提供了能够调节 HIF1α 的拟肽大环以及使用这种大环治疗疾病的方法。
TETRACYCLINE COMPOUNDS
申请人:Tetraphase Pharmaceuticals, Inc.
公开号:US20170044160A1
公开(公告)日:2017-02-16
The present invention is directed to a compound represented by Structural Formula (I):
or a pharmaceutically acceptable salt thereof. The variables for Structural Formula I are defined herein.
Also described is a pharmaceutical composition comprising the compound of Structural Formula I and its therapeutic use.